The Public Financing of Pharmaceuticals
Show Less

The Public Financing of Pharmaceuticals

An Economic Approach

Edited by Jaume Puig-Junoy

This book provides a complete approach to the economics of financing medicines and policy implications for the efficiency and equity of health systems. In all health systems with majority public financing, pharmaceutical reimbursement is one of the key factors in policies of change and transformation of health services in order to face the future with guarantees of financial sustainability.
Buy Book in Print
Show Summary Details

Chapter 5: Mechanisms to encourage price competition in the pharmaceutical market and their effects on efficiency and welfare

J. Rovira Forns and J. Darbà Coll

Extract

5. Mechanisms to encourage price competition in the pharmaceutical market and their effects on efficiency and welfare J. Rovira Forns and J. Darbà Coll INTRODUCTION Mainstream economics presupposes that the market is, in conditions of perfect competition, an automatic mechanism for resource allocation that leads to allocative efficiency, that is, allows the maximization of consumers’ welfare with available resources. On this basis, liberal economists tend to defend that public powers should abstain from intervening in or regulating the market, assuming that the result of any intervention will distort resource assignation and cause efficiency and welfare losses for society. Nevertheless, even those economists who are most staunchly in favour of the free market acknowledge that there are situations in which laissez-faire, the inhibition of the public powers, is not the best course of action. The first of these situations consists of what is known as market failures; in other words, cases in which the market does not give an efficient response: public goods, externalities, information asymmetry and so on. In these cases, there is widespread consensus in the discipline that public intervention is necessary to reach an efficient solution. However, this does not mean that just any sort of intervention is justified, as there may be problems or failures in the public regulation, causing the result to be worse than if there had been no intervention. As the saying goes, in terms that are curiously relevant to the matter in hand, sometimes the remedy is worse than the disease. Another case...

You are not authenticated to view the full text of this chapter or article.

Elgaronline requires a subscription or purchase to access the full text of books or journals. Please login through your library system or with your personal username and password on the homepage.

Non-subscribers can freely search the site, view abstracts/ extracts and download selected front matter and introductory chapters for personal use.

Your library may not have purchased all subject areas. If you are authenticated and think you should have access to this title, please contact your librarian.


Further information

or login to access all content.